June 7, 2017Open Access

Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia

Key Points

Key points are not available for this paper at this time.

Abstract

Clozapine and long-acting injectable antipsychotic medications were the pharmacologic treatments with the highest rates of prevention of relapse in schizophrenia. The risk of rehospitalization is about 20% to 30% lower during long-acting injectable treatments compared with equivalent oral formulations.

AI से पूछें

Bookmark

View Full Paper

Cite This Study

Tiihonen et al. (Wed,) studied this question.

synapsesocial.com/papers/69da22dc387cf7069868623a https://doi.org/https://doi.org/10.1001/jamapsychiatry.2017.1322

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Mortality and Cumulative Exposure to Antipsychotics, Antidepressants, and Benzodiazepines in Patients With Schizophrenia: An Observational Follow-Up Study2015 · 205 citations
2A Meta-analysis of the Efficacy of Second-Generation Antipsychotics2003 · 1,043 citations
3Agreement between PRE2DUP register data modeling method and comprehensive drug use interview among older persons2016 · 72 citations
4Antipsychotic Polypharmacy and Risk of Death From Natural Causes in Patients With Schizophrenia2009 · 125 citations
5Comparative effectiveness and safety of antipsychotic drugs in schizophrenia treatment: a real‐world observational study2016 · 72 citations

AI से पूछें

Bookmark

View Full Paper

Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia

Key Points

Abstract

Cite This Study

Also Consider

Also Consider

Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia